Growth inhibitory and cytotoxic effects of melatonin and its metabolites on human tumour cell lines in vitro.
Shellard
S A
SA
Laboratory of Cellular Chemotherapy, Imperial Cancer Research Fund, Lincoln's Inn Fields, London, UK.
Whelan
R D
RD
Hill
B T
BT
D015115:5,6-Dihydroxytryptamine / Q000627:therapeutic use; D008735:5-Methoxytryptamine / Q000627:therapeutic use; D002460:Cell Line; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D008550:Melatonin / Q000031:analogs & derivatives / Q000627:therapeutic use*; D012701:Serotonin / Q000031:analogs & derivatives / Q000627:therapeutic use; D014363:Tryptamines / Q000627:therapeutic use; D014407:Tumor Cells, Cultured / Q000187:drug effects*
D014363:Tryptamines; D012701:Serotonin; D008735:5-Methoxytryptamine; C030820:tryptamine; D008550:Melatonin; C006389:N-acetylserotonin; C012365:6-hydroxymelatonin; D015115:5,6-Dihydroxytryptamine